Clinical trials
Observational Hypertension, Pulmonary trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 3 |
| 2011 | 4 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 8 |
| Unknown status | 8 |
| Enrolling by invitation | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Giessen | 11 |
| Bayer | 5 |
| Heidelberg University | 3 |
| Hannover Medical School | 2 |
| Actelion | 1 |
| Association for Pediatric Pulmonary Hypertension | 1 |
| Ayham Daher | 1 |
| Charite University, Berlin, Germany | 1 |
| Competence Network for Congenital Heart Defects | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 40 |
| Pulmonary Arterial Hypertension | 11 |
| Heart Failure | 5 |
| Familial Primary Pulmonary Hypertension | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Scleroderma, Systemic | 2 |
| Asthma | 1 |
| Cardio-Renal Syndrome | 1 |
| Congenital Portosystemic Shunt | 1 |
| Connective Tissue Diseases | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.